Introduction. Thoracic surgery is associated with high levels of pain.
other mechanism of magnesium action is reduction of catecholamine release due to sympathetic stimulation, thus decreasing peripheral sensitization of nociceptors in the stress response to operative procedure. (4) (5) (6) Trials with intrathecal and epidural magnesium administration have shown that magnesium is a valuable adjuvant analgesic, but very few data are available on its analgesic effects in lung resection surgery. (7) (8) (9) (10) The aim of the present study was to assess effects of continuous epidural magnesium infusion during thoracic surgery on intraoperative sufentanil consumption and postoperative analgesic requirements during first 48 hours after surgery.
Materials and methods
Ethical approval for this study (Ethical Committee N°380-59-1016- This prospective placebo-controlled randomized study included 70 ASA I-III patients undergoing elective thoracic surgery. Exclusion criteria were patients with major liver or kidney impairment, neuromuscular disease, II-III degree AV block, extreme obesity, and those exposed to opioids and/or calcium channel blockers before surgery.
Seventy patients were randomized into two groups of 35 patients: group 1 (magnesium group) received an epidural with10% magnesium sulphate (MgSO 4 ) along with anesthetic drugs, and group 2 (control group) received an epidural with 0.9% sodium chloride (NaCl) solution along with anesthetic drugs intraoperative. Postoperatively, group 1 patients were administered an epidural with 10% magnesium sulphate in addition to local anesthetic and opioid, whereas group 2 patients were administered local anesthetic and opioid alone. depression, pruritus, nausea and vomiting; therefore, adding to the epidural mixture a drug that can reduce the analgesic dose of opioid is highly welcome. In elderly patients and in those with chronic obstructive pulmonary disease higher doses of opioid analgesic may increase the rate of serious side effects. (3) Our study showed that the cumulative dose of opioid administered intraoperatively is significantly lower in group M patients as compared with group C, either comparing the total dosage or dose per kg body weight.
Total doses of levobupivacaine and sufentanil administered over 48 h postoperatively were significantly lower in group M patients that received magnesium in addition to sufentanil and levobupivacaine. The patients administered magnesium sulphate had lower VAS values for pain at rest and on coughing and movement throughout the 48-h period.
All these differences were statistically significant. In thoracotomy patients, the positive effects of reduced doses of local anesthetics administered postoperatively contribute to better hemodynamic stability, fast recovery of physiologic diaphragm movements, increase the functional residual capacity and lung volume, while maintaining the intercostal musculature strength necessary for efficient expectoration. (22) Therefore, we believe that the low doses of total levobupivacaine administered postoperatively in our group of thoracic surgery patients, who received magnesium in addition to sufentanil and levobupivacaine, could had a favourable effect.
The results of our study indicate that satisfactory hemodynamic stability was maintained in both patient groups, while systolic and diastolic pressure and pulse values were comparable on all measurements and SIGNA VITAE 2016; 11(1): differences did not reach statistical significance.
In our study, the rate of postoperative nausea, vomiting, pruritus and postoperative shivering was lower in the group of patients administered magnesium. The difference pointed to the antiemetic action of magnesium, or to an indirect effect because of the lower need of opioids in the group of patients administered magnesium.
Shivering is an involuntary, oscillating muscular activity that stimulates metabolic activity by the increased oxygen consumption and the formation of carbon dioxide of up to 800% basal values. Postoperative hypertension increases the intensity of sympathetic activity, peripheral vascular resistance and the risk of myocardial ischemia, along with the occurrence of dysrhythmias, in particular threatening patients with existing ischemic heart disease and reduced respiratory reserve.
The sedation score did not differ significantly between the two groups.
There was no excessive drowsiness or respiratory depression in the group of patients administered magnesium, which is consistent with the reports by Bilir et al. and El Kerdawy et al. (7, 14) We recorded no neurologic complications that could be associated with epidural magnesium.
The magnesium safety profile relative to the CNS was evaluated in experimental dog and rat models. Results showed the use of magnesium to have prevented spinal injury in spite of severe ischemia, and did not cause any histopathological lesions of neural structures.
Literature data show that accidental epidural administration of high doses of magnesium (8.7-9.6 g) and intrathecal administration of 1000 mg caused no neurologic lesion except for transient motor blockade (Goodman et al., Lejuste et al.) . (25, 26) The present study limitation was the use of only one dose -response evaluation, and lack of determination of cerebrospinal fluid magnesium concentration as this was considered to be invasive.
Conclusion
SIGNA VITAE 2016; 11 (1): Results of the present study indicate that the addition of magnesium in the epidural mixture of sufentanil and bupivacaine led to more efficient intraoperative and postoperative analgesia and to lower utilization of sufentanil and bupivacaine.
We observed a lower rate of nausea, vomiting, pruritus and postoperative shivering.
The magnesium dosage used in the study was associated with normal hemodynamic and respiratory status of patients.
We can conclude, that, based on the favorable effects recorded, epidural magnesium appears to be a useful adjunct to anesthesiologic drugs, which can exert positive effects on the course and outcome of thoracic surgery procedures. 
